Smoking Status on Outcomes After Percutaneous Coronary Intervention

被引:25
作者
Chen, Tao [1 ,2 ]
Li, Wei [1 ,2 ]
Wang, Yang [1 ,2 ]
Xu, Bo [1 ,2 ]
Guo, Jin [1 ,2 ]
机构
[1] Chinese Acad Med Sci, Peking Union Med Coll, Med Res & Biometr Ctr, State Key Lab Cardiovasc Dis,Cardiovasc Inst, Beijing 100730, Peoples R China
[2] Chinese Acad Med Sci, Fuwai Hosp, Natl Ctr Cardiovasc Dis, State Key Lab Cardiovasc Dis,Dept Cardiol, Beijing 100730, Peoples R China
关键词
ACUTE MYOCARDIAL-INFARCTION; LONG-TERM OUTCOMES; SMOKERS PARADOX; HEART-DISEASE; MORTALITY; IMPACT; CESSATION; REVASCULARIZATION; TRIAL; RISK;
D O I
10.1002/clc.22004
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: The effect of smoking on prognosis among patients undergoing percutaneous coronary intervention (PCI) is controversial, and data on the importance of smoking cessation or reductions were lacking. Hypothesis: Smoking cessation or reductions could reduce the risk of adverse outcomes in patient after PCI. Methods: There were 19 506 consecutive patients who had undergone successful PCI between April 2004 and January 2010 followed. Extensive data, including self-reported smoking habits, were obtained at baseline and during follow-up. Results: Compared with post-PCI quitters and persistent smokers, the nonsmokers and pre-PCI quitters were older and had a higher prevalence of comorbid factors such as hypertension and impaired left ventricle function. The adjusted hazard ratios for mortality were 2.52 (95% confidence interval [CI]: 1.923.30) for nonsmokers, 0.52 (95% CI: 0.320.84) for pre-PCI quitters, and 0.11 (95% CI: 0.060.22) for post-PCI quitters, compared to persistent smokers. With respect to additional revascularizations, a higher risk was observed among the quitters (1.70 [95% CI: 1.402.08] for pre-PCI quitters and 1.59 [95% CI: 1.361.85] for post-PCI quitters) as well as the nonsmokers (1.40 [95% CI: 1.201.64]). Among persistent smokers, each reduction of 5 cigarettes/day was associated with a 72% decline in mortality risk (P < 0.001) but did not reach statistical significant for repeated revascularizations (0.80 [95% CI: 0.461.37], P = 0.4132). Conclusions: Despite a higher risk of revascularization, the cessation of smoking either before or after PCI is beneficial in all-cause mortality. The apparent smoker's paradox may be explained by the differences in baseline risk or the reduced sensitivity to adverse outcomes as well as the reluctance to seek medical help among smokers. This study received an unrestricted grant from Pfizer Investment Co., China. The authors have no other funding, financial relationships, or conflicts of interest to disclose.
引用
收藏
页码:570 / 574
页数:5
相关论文
共 28 条
[1]  
Andrikopoulos GK, 2002, CIRCULATION, V105, pE55
[2]   In-hospital mortality of habitual cigarette smokers after acute myocardial infarction - The 'smoker's paradox' in a countrywide study [J].
Andrikopoulos, GK ;
Richter, DJ ;
Dilaveris, PE ;
Pipilis, A ;
Zaharoulis, A ;
Gialafos, JE ;
Toutouzas, PK ;
Chimonas, ET .
EUROPEAN HEART JOURNAL, 2001, 22 (09) :776-784
[3]   The effects of a smoking cessation intervention on 14.5-year mortality - A randomized clinical trial [J].
Anthonisen, NR ;
Skeans, MA ;
Wise, RA ;
Manfreda, J ;
Kanner, RE ;
Connett, JE .
ANNALS OF INTERNAL MEDICINE, 2005, 142 (04) :233-239
[4]  
Aygul Nazif, 2010, Clin Cardiol, V33, pE49, DOI 10.1002/clc.20716
[5]   SIGNIFICANCE OF SMOKING IN PATIENTS RECEIVING THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL-INFARCTION - EXPERIENCE GLEANED FROM THE INTERNATIONAL TISSUE PLASMINOGEN-ACTIVATOR STREPTOKINASE MORTALITY TRIAL [J].
BARBASH, GI ;
WHITE, HD ;
MODAN, M ;
DIAZ, R ;
HAMPTON, JR ;
HEIKKILA, J ;
KRISTINSSON, A ;
MOULOPOULOS, S ;
ERNESTO ;
PAOLASSO ;
VANDERWERF, T ;
PEHRSSON, K ;
SANDOE, E ;
SIMES, J ;
WILCOX, RG ;
VERSTRAETE, M ;
VONDERLIPPE, G ;
VANDEWERF, F .
CIRCULATION, 1993, 87 (01) :53-58
[6]   Health consequences of smoking 1-4 cigarettes per day [J].
Bjartveit, K ;
Tverdal, A .
TOBACCO CONTROL, 2005, 14 (05) :315-320
[7]   C-reactive protein and prognosis after percutaneous coronary intervention [J].
Blake, GJ ;
Ridker, PM .
EUROPEAN HEART JOURNAL, 2002, 23 (12) :923-925
[8]   Impact of smoking on clinical and angiographic restenosis after percutaneous coronary intervention - Another smoker's paradox? [J].
Cohen, DJ ;
Doucet, M ;
Cutlip, DE ;
Ho, KKL ;
Popma, JJ ;
Kuntz, RE .
CIRCULATION, 2001, 104 (07) :773-778
[9]   Mortality risk reduction associated with smoking cessation in patients with coronary heart disease - A systematic review [J].
Critchley, JA ;
Capewell, S .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (01) :86-97
[10]   Impact of Smoking on Cardiovascular Events in Patients With Coronary Disease Receiving Contemporary Medical Therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] Trials) [J].
Frey, Paul ;
Waters, David D. ;
DeMicco, David A. ;
Breazna, Andrei ;
Samuels, Larry ;
Pipe, Andrew ;
Wun, Chuan-Chuan ;
Benowitz, Neal L. .
AMERICAN JOURNAL OF CARDIOLOGY, 2011, 107 (02) :145-150